Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

HD-SC Elucidating the Superior Colliculus-related network properties and modulation in Huntington's Disease mouse model to delay the onset and ameliorate severity of the motor symptoms

Coordinator
Universitat De Barcelona, Spain
Runs
1 October 2023 to 31 October 2025
Status
Running
EU funding
€165k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101104889

What the project is doing

In the project's own words, from its summary on CORDIS.

Neurodegenerative movement disorders e.g. Huntington’s Disease (HD) predominantly involve progressive motor symptoms as a result of disrupted basal ganglia neuronal networks. These symptoms are accompanied by early occurring deficits in visual perception and oculomotor functions, which share neuronal circuits with motor domains, and can be used in the prediction of the onset and severity of HD pathogenesis. Therefore, understanding the early circuitry alterations in HD progression is crucial to develop new disease-modifying strategies.

The superior colliculus (SC) is a sensorimotor structure that receives and integrates visual information to control reflexes and is involved in visual perception and oculomotor functions. Functional MRI and behavioural studies demonstrated that the HD symptomatic mouse model show alterations in the SC function, but its role in motor symptoms has not been directly addressed. The HD-SC project proposes that (i) SC is an important factor in the basal ganglia circuit alterations found in HD, (ii) topographically segregated SC outputs provide differential contributions to the motor and defensive behaviours, and (iii) temporal control of SC neuronal plasticity with novel phytochromes will cause delay and amelioration in motor symptoms in HD model.

This will be addressed using a combination of mouse behavioural, histological and biochemical phenotyping to reveal the onset of SC-related alterations in the HD model. Then, by using DREADDS we will determine the differential representation of SC outputs in motor and defensive behaviour. Finally, we will test the capability of phytochromes to modulate SC neuronal plasticity and delay and ameliorate motor symptoms in the HD model.

Overall, the HD-SC aims at bringing a spotlight to mechanisms causing symptomatic resilience in the HD model, which potentially could be implemented in other neurodegenerative movement disorders with basal ganglia circuit alterations.

Who is involved

OrganisationCityCountryRole
Universitat De BarcelonaBarcelonaSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI